What question did this study set out to answer?

To evaluate and compare the diagnostic performance of a new NT-proBNP assay against brain natriuretic peptide (BNP) in identifying left ventricular systolic dysfunction within community populations.

July 14, 2004HeartOpen Access

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

View Full Paper

Ask AI

Bookmark

Why the study?

Does the NT-proBNP assay perform comparably to the BNP assay in identifying left ventricular systolic dysfunction in community populations?

Key Points

To evaluate and compare the diagnostic performance of a new NT-proBNP assay against brain natriuretic peptide (BNP) in identifying left ventricular systolic dysfunction within community populations.
Prospective community-based screening of 591 randomly sampled adults aged over 45 years, stratified by age and socioeconomic status across four cohorts (general population, diagnosed heart failure, diuretic users, and high risk).
Conducted blinded laboratory assays on routine blood samples, defining definite left ventricular systolic dysfunction as a left ventricular ejection fraction < 40% (identified in 33 participants).
In the general population, NT-proBNP at a cutoff of > 40 pmol/l yielded 80% sensitivity, 73% specificity, 5% PPV, 100% NPV, and an AUC of 76% (95% CI 46% to 100%).
BNP at a cutoff of > 33 pmol/l demonstrated 80% sensitivity, 88% specificity, 10% PPV, 100% NPV, and an AUC of 88% (95% CI 75% to 100%), with both assays showing consistently high NPV across all cohorts.

Structured PICO

Does the NT-proBNP assay perform comparably to the BNP assay in identifying left ventricular systolic dysfunction in community populations?

Population

591 randomly sampled individuals over the age of 45 years from the community, stratified for age and socioeconomic status, divided into four cohorts (general population; clinically diagnosed heart failure; patients on diuretics; and patients deemed at high risk of heart failure). Definite heart failure (LVEF < 40%) was identified in 33 people.

Intervention

NT-proBNP assay

Comparator

BNP assay

Outcome

Diagnosis of left ventricular systolic dysfunction (LVEF < 40%)surrogate

Both NT-proBNP and BNP assays demonstrate high negative predictive value for ruling out left ventricular systolic dysfunction in community populations.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May favor BNP for community LVSD screening; leaves open prospective validation before practice change.

Cite This Study

Richard Hobbs (2004) studied this question.

synapsesocial.com/papers/6a814523ada1eccddc33ac2e https://doi.org/10.1136/hrt.2003.014258

View Full Paper

Ask AI

Bookmark

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider